Taketo Ezaki, Kouki Kishima, Shunsuke Shibao, Takuya Matsunaga, Eriel Sandika Pareira, Yohei Kitamura, Yuji Nakayama, Noboru Tsuda, Kento Takahara, Takashi Iwama, et al. Development of microsurgical forceps equipped with haptic technology for in situ differentiation of brain tumors during microsurgery. Scientific Reports. 2024. 14. 1
Toshihide Tanaka, Jun Takei, Hikaru Sasaki. Response to correspondence on an exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma. Journal of Neuro-Oncology. 2024
Taketo Ezaki, Toshihide Tanaka, Ryota Tamura, Kentaro Ohara, Yohei Yamamoto, Jun Takei, Yukina Morimoto, Ryotaro Imai, Yuki Kuranai, Yasuharu Akasaki, et al. Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment. Brain Tumor Pathology. 2024. 41. 2. 61-72
Hikaru Sasaki, Yohei Kitamura, Masahiro Toda, Yuichi Hirose, Kazunari Yoshida. Oligodendroglioma, IDH-mutant and 1p/19q-codeleted-prognostic factors, standard of care and chemotherapy, and future perspectives with neoadjuvant strategy. Brain tumor pathology. 2024
Toshihide Tanaka, Ryota Tamura, Jun Takei, Yukina Morimoto, Akihiko Teshigawara, Yohei Yamamoto, Ryotaro Imai, Yuki Kuranari, Kyoichi Tohmoto, Yuzuru Hasegawa, et al. An exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma. Journal of Neuro-Oncology. 2024. 166. 3. 557-567
ANGI-1 Regulation of alternative angiogenic factors in bevacizumab therapy for glioblastoma. 2023. 5. 5. v1-v2
Toshihide Tanaka, Ryota Tamura, Jun Takei, Yukina Morimoto, Akihiko Teshigawara, Kyoichi Tohmoto, Yuki Kuranari, Ryotaro Imai, Yohei Yamamoto, Yuzuru Hasegawa, et al. 10001-ACT-1 A MULTICENTER EXPLORATORY PHASE II STUDY OF NEOADJUVANT BEVACIZUMAB FOR NEWLY DIAGNOSED MALIGNANT GLIOMA - THE SECOND REPORT. Neuro-Oncology Advances. 2023. 5. Supplement_5. v1-v1
Hikaru Sasaki, Tokunori Kanazawa, Yohei Kitamura, Masato Nakaya, Hirokazu Fujiwara, Tokuhiro Kimura, Shunsuke Nakae, Shigeo Ohba, Yuya Nishiyama, Masahiro Toda, et al. LW-8 TREATMENT STRATEGY FOR OLIGODENDROGLIOMAS WITH NEOADJUVANT STRATEGY AND STAGED RESECTION UTILIZING THEIR CHEMOTHERAPEUTIC RESPONSIVENESS. Neuro-Oncology Advances. 2022. 4. Supplement_3. iii27-iii27
Tanaka T, Tamura R, Takei J, Morimoto Y, Teshigawara A, Tohmoto K, K, Kuranari Y, Imai R, Yamamoto Y, et al. A prospective multicenter phase I/IIa study of prospective neoadjuvant bevacizumab for newly diagnosed glioblastoma. Neuro-Oncology Advances. 2022. 4. 3. iii7
日本頭蓋底外科学会
, 日本脳腫瘍の外科学会
, Society for Neuro-Oncology (SNO)
, 日本分子脳神経外科学会
, JCOG(日本臨床腫瘍研究グループ)脳腫瘍グループ
, 日本癌学会
, 日本臨床腫瘍学会
, 日本癌治療学会
, 日本脳腫瘍病理学会
, American Association for Cancer Research (AACR, active membership)
, 日本脳神経外科コングレス
, 日本脳腫瘍学会
, 日本脳神経外科学会